I have had MASSIVE changes after 5 days of 500mg of methylprednisolone in the legs. The steroids have had the most AMAZING effects on my bad legs this time around. I have never experienced so much change from steroids. The effects have not been all positive but extraordinary with outstanding tingling and spasms alternating with vast volumes or urine and sweating and then appalling constipation and hugely reduced spasticity and enhanced flexibility of the feet and knee...I have no idea what is going on but the steroids have certainly changed things MASSIVELY!!!! I am going to try to pulse high dose steroids every 6 months or so for the next year to 2 years to get that inflammation down.
Very impressed.
J Neurol Sci. 2005 Jun 15;233(1-2):73-81.
Steroids and brain atrophy in multiple sclerosis.
Zivadinov R.
Source
Department of Neurology, SUNY-University at Buffalo School of Medicine and Biomedical, Sciences, Buffalo, NY, USA.
rzivadinov@thejni.orgAbstract
In this review, we focus on different pathogenetic mechanisms of corticosteroids that induce short- and long-term brain volume fluctuations in a variety of systemic conditions and disorders, as well as on corticosteroid-induced immunomodulatory, immunosuppressive and anti-inflammatory mechanisms that contribute to the slowdown of brain atrophy progression in patients with multiple sclerosis (MS). It appears that chronic low-dose treatment with corticosteroids may contribute to irreversible loss of brain tissue in a variety of autoimmune diseases. This side effect of steroid therapy is probably mediated by steroid-induced protein catabolism mechanism. Evidence is mounting that high-dose corticosteroids may induce reversible short-term brain volume changes due to loss of intracellular water and reduction of abnormal vascular permeability, without there having been axonal loss. Other apoptotic and selective inhibiting mechanisms have been proposed to explain the nature of corticosteroid-induced brain volume fluctuations. It has been shown that chronic use of high dose intravenous methylprednisolone (IVMP) in patients with MS may limit brain atrophy progression over the long-term via different immunological mechanisms, including downregulation of adhesion molecule expression on endothelial cells, decreased cytokine and matrix metalloproteinase secretion, decreased autoreactive T-cell-mediated inflammation and T-cell apoptosis induction, blood-brain barrier closure, demyelination inhibition and, possibly, remyelination promotion. Studies in nonhuman primates have confirmed that short-term brain volume fluctuations may be induced by corticosteroid treatment, but that they are inconsistent, potentially reversible and probably dependent upon individual susceptibility to the effects of corticosteroids. Further longitudinal studies are needed to elucidate pathogenetic mechanisms contributing to brain volume fluctuations in autoimmune diseases and multiple sclerosis.
PMID: 15882880 [PubMed - indexed for MEDLINE]